CBD-Intel

South America

You’ll find all of our South American content on this page. You’ll be able to explore our full-length market and regulatory reports, browse through out business and regulatory news briefings, and access our many trackers and databases.

South America and Latin America are seen as CBD markets with significant potential but regulatory and market conditions differ. Our coverage includes industry outlook, market developments, regulatory issues and policy on CBD and cannabis.

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions